C1000

Amersfoort, Netherlands Founded: 1977 • Age: 49 yrs Acquired By Jumbo
PCR reagents, microplate systems, and electrophoresis kits are distributed.

About C1000

C1000 is a Healthcare company based in Amersfoort (Netherlands) founded in 1977, and was acquired by Jumbo in November 2011. PCR reagents, microplate systems, and electrophoresis kits are distributed. Its focus areas include Medical Device Distributors.

Company details

C1000 was founded in 1977 and is based in Amersfoort, Netherlands. Operations focus on the distribution of laboratory supplies within the life sciences sector. PCR reagents, microplate systems, and electrophoresis kits are provided to support research and diagnostic applications. The company serves clients across Europe through its established network, emphasizing reliable supply chain management for scientific tools.

Key Metrics

Investors in C1000

C1000 has secured backing from 1 investor. Prominent investors backing the company include Jumbo.

All
InvestorDescriptionFounded YearDomainLocation
Daily groceries are provided at consistently low prices by Jumbo.
jumbo.comNetherlands
Premium access

Investor details for C1000

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of C1000

2 dated milestones of C1000 across 34 years, from founding to its latest funding, stage changes and deals.

  1. Founded C1000 is founded.
  2. Exit Acquired by Jumbo.

Web traffic of C1000

Websites that share an audience with C1000 (c1000.nl).

Similar websites

Websites whose visitors overlap most with C1000. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
emte.nl
82%
View details
agrimarkt.nl
80%
View details
vd.nl
77%
246.2K#142,647View details
plus.nl
73%
2.3M#22,141View details
xenos.nl
68%
1.7M#28,475View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 7 similar websites and full traffic analytics for C1000

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 7 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about C1000

C1000 was founded in 1977.

C1000 is headquartered in Amersfoort, Netherlands. It is registered at Amersfoort, Utrecht, Netherlands.

C1000 was founded in 1977 and is based in Amersfoort, Netherlands. Operations focus on the distribution of laboratory supplies within the life sciences sector. PCR reagents, microplate systems, and electrophoresis kits are provided to support research and diagnostic applications. The company serves clients across Europe through its established network, emphasizing reliable supply chain management for scientific tools.

C1000 has 1 investor. Key investors include Jumbo.

Yes. C1000 was acquired by Jumbo in November 2011.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available